{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:6021",
      "entity_text" : "inosine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P55263",
      "entity_text" : "adenosine kinase",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The protective effects are also partially dependent on adenosine kinase, as the inhibitor 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl) pyrido [2,3-d] pyrimidine, 2HCl (ABT 702, 30 muM) significantly reversed the protective effect of both adenosine and inosine during hypoxia and re-oxygenation.",
  "reading_complete" : "2020-08-02T10:55:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:53:30Z",
  "trigger" : "reversed",
  "evidence" : [ "adenosine kinase, as the inhibitor 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, 2HCl (ABT 702, 30 muM) significantly reversed the protective effect of both adenosine and inosine" ],
  "pmc_id" : "3981016",
  "score" : 0
}